Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lilliput APD System

K-Number: K212522 · 2022-04-15

Decision Date2022-04-15
Product CodeFKX
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Lilliput APD System is a medical device manufactured by Fresenius Medical Care Renal Therapies Group, LLC. It received FDA 510(k) clearance on 2022-04-15 under approval number K212522. The device is classified under product code FKX. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lilliput APD System?

Lilliput APD System is a medical device that received FDA 510(k) clearance on 2022-04-15. It is manufactured by Fresenius Medical Care Renal Therapies Group, LLC. The 510(k) number is K212522.

When was Lilliput APD System approved by the FDA?

Lilliput APD System received FDA 510(k) clearance on 2022-04-15, under approval number K212522.

What company makes Lilliput APD System?

Lilliput APD System is manufactured by Fresenius Medical Care Renal Therapies Group, LLC.

What is the FDA product code for Lilliput APD System?

The FDA product code for Lilliput APD System is FKX.

Other Devices by Fresenius Medical Care Renal Therapies Group, LLC

View all 47 devices →

Related Devices (Code: FKX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.